- Komentář k výsledkům studie PACIFIC po 3 letech terapie2020 | First Faculty of Medicine
- Clinical experience with durvalumab treatment2021 | First Faculty of Medicine
- Indikace durvalumabu v léčbě pacientů s bronchogenním karcinomem2023 | First Faculty of Medicine
- Komentář ke studii2020 | First Faculty of Medicine
- Treatment of locally advanced NSCLC in the context of current guidelines2021 | Publication without faculty affiliation
- Non-small cell lung cancer radiotherapy and consolidation therapy with durvalumab2020 | Third Faculty of Medicine
- Durvalumab in the treatment of lung cancer2019 | Second Faculty of Medicine